Assessment of No Evidence of Disease Activity (NEDA-3) in alemtuzumab-treated patients with aggressive multiple sclerosis who failed multiple disease-modifying drugs

被引：0

作者：

Prosperini, L. ^{[1
]}

Annovazzi, P. ^{[2
]}

Boffa, L. ^{[3
]}

Buscarinu, C. ^{[4
]}

Gallo, A. ^{[5
]}

Matta, M. ^{[6
]}

Moiola, L. ^{[7
]}

Musu, L. ^{[8
]}

Perini, P. ^{[9
]}

Avolio, C. ^{[10
]}

Rottoli, M. R. ^{[11
]}

Bianco, A. ^{[12
]}

Farina, D. ^{[13
]}

Ferraro, E. ^{[14
]}

Francia, A. ^{[1
]}

Granella, F. ^{[15
]}

Grimaldi, L. ^{[16
]}

Laroni, A. ^{[17
]}

Lus, G. ^{[5
]}

Patti, F. ^{[18
]}

Pucci, E. ^{[19
]}

Repice, A. M. ^{[20
]}

Sarchielli, P. ^{[21
]}

机构：

[1] Univ Roma La Sapienza, Neurol & Psychiat, Rome, Italy

[2] S Antonio Abate Hosp, Gallarate, Italy

[3] Univ Roma Tor Vergata, Rome, Italy

[4] S Andrea Hosp, Ctr Expt Neurol Therapies CENTERS, Rome, Italy

[5] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy

[6] S Luigi Gonzaga Hosp, Reg MS Ctr, Orbassano, Italy

[7] Univ Vita Salute San Raffaele, S Raffaele Sci Inst, Milan, Italy

[8] ASL 8 Cagliari Univ, Cagliari, Italy

[9] Univ Hosp, MS Ctr, Dept Neurosci, Padua, Italy

[10] Univ Hosp, Dept Med & Surg Sci, Foggia, Italy

[11] Papa Giovanni XXIII Hosp, Bergamo, Italy

[12] Sch Med A Gemelli, Inst Neurol, Rome, Italy

[13] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy

[14] S Filippo Neri Hosp, Rome, Italy

[15] Univ Parma, Dept Neurosci, Parma, Italy

[16] Fdn Ist San Raffaele G Giglio, Cefalu, Italy

[17] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy

[18] Univ Catania, Neurosci Sect, Dept Med & Surg Sci & Adv Technol, Catania, Italy

[19] ASUR Marche AV3, Neurol Unit, Macerata, Italy

[20] Careggi Hosp, Neurol Unit, Florence, Italy

[21] Univ Perugia, Neurol Unit, Perugia, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P614

引用

页码：284 / 285

页数：2

共 50 条

[21] Development and validation of a claimsbased measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs
Munsell, Michael
Frean, Molly
Menzin, Joseph
Phillips, Amy L.
BMC NEUROLOGY, 2017, 17
[22] A population-based assessment of "no evidence disease activity" (NEDA) in multiple sclerosis
Parks, N. E.
Pittock, S. J.
Mandrekar, J.
Kantarci, O. H.
Lucchinetti, C. F.
Weinshenker, B. G.
Keegan, B. M.
Tobin, W. O.
Tillema, J. -M.
Toledano, M.
Flanagan, E. P.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 125 - 126
[23] Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab
Pfeuffer, Steffen
Ruck, Tobias
Pul, Refik
Rolfes, Leoni
Korsukewitz, Catharina
Pawlitzki, Marc
Wildemann, Brigitte
Klotz, Luisa
Kleinschnitz, Christoph
Scalfari, Antonio
Wiendl, Heinz
Meuth, Sven G.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (09): : 1007 - 1013
[24] Improving adherence to injectable disease-modifying drugs in multiple sclerosis
Bayas, Antonios
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (03) : 285 - 287
[25] Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland
Bailey, B.
IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 (02) : 337 - 341
[26] Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland
B. Bailey
Irish Journal of Medical Science, 2011, 180 : 337 - 341
[27] Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis
Ng, Huah Shin
Zhu, Feng
Zhao, Yinshan
Yao, Shenzhen
Lu, Xinya
Ekuma, Okechukwu
Evans, Charity
Fisk, John D.
Marrie, Ruth Ann
Tremlett, Helen
NEUROLOGY, 2024, 102 (03) : e208006
[28] Disease-Modifying drugs in multiple sclerosis: Current therapeutic schemes
Jose Rios Martinez, Maria
Arteaga, Anibal
Henao, Julieta
Vagner, Basilio
Fredy Castro-Alvarez, John
REVISTA CHILENA DE NEUROPSICOLOGIA, 2020, 15 (01): : 32 - 37
[29] Disease-modifying drugs for multiple sclerosis: current and future aspects
Freedman, Mark S.
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 : S1 - S10
[30] Disease-Modifying Drugs for Multiple Sclerosis in Pregnancy: A Systematic Review
Lu, Ellen
Wang, Bing Wei
Guimond, Colleen
Synnes, Anne
Sadovnick, Dessa
Tremlett, Helen
NEUROLOGY, 2012, 78

← 1 2 3 4 5 →